Dabur India Ltd is a leading FMCG company of the country with a legacy of 139 years. The Ghaziabad-based company is one of the largest Ayurvedic and natural health care products company, with a portfolio of over 250 products.
Dabur began its journey from the bylanes of erstwhile Calcutta (now Kolkata) when an Ayurvedic practitioner Dr. SK Burman launched it as a small Ayurvedic medicines company in 1884. The company set up its first manufacturing plant in 1896.
In the early years of the 20th century, the company set up research laboratories and established manufacturing plants in West Bengal as its operations expanded to the Northeastern states and Bihar. In 1936, it became a full-fledged company incorporated as Dabur India (Dr. SK Burman) Pvt. Ltd.
The company shifted its base to Delhi in 1972, setting up a manufacturing unit in Faridabad, Haryana. Seven years later, it kickstarted the Dabur Research & Development Centre (DRDC) and in 1982 became a Public Limited Company, Dabur India Ltd.
In 1992, Dabur entered into its first foreign tie-up with forming a strategic joint venture with Agrolimen of Spain to manufacture and market confectionery items in India. The next year, it forayed into the specialised healthcare area of cancer treatment by establishing an oncology formulation plant at Baddi in Himachal Pradesh.
In 1994, Dabur launched its first public issue which was oversubscribed 21 times.
The company extended its global partnerships in 1995, forming Joint Ventures with Israel’s Osem for food and Bongrain of France for dairy products.
The FMCG major entered full-throttle the then emerging processed foods market in 1997 by creating a Foods Division. Its turnover crossed the ₹1000 crore mark in 2000.
In 2007, Dabur India ventured into the organised retail business segment through a wholly-owned subsidiary, H&B Stores Limited. In 2010, the company made its first overseas acquisitions. It took over Hobi Kozmetik Group, a leading Turkish personal care products company for $69 Million, and picked up 100% equity in Namaste Laboratories LLC of the US for $100 Million.
The company’s market capitalisation stood at over ₹ 94,600 crore as of December 27, 2023. Dabur share price has gone up nearly 4% in the last three years.
Business operations
Dabur primarily operates in key consumer product categories like health care, hair care, oral care, skin care, home care, hygiene and food & beverages. It has 22 manufacturing units, including eight abroad, and caters to the market in over 120 countries across four continents with its wide distribution network of 7.7 million retail outlets.
The company has a significant presence in the Middle East, SAARC countries, Africa, the United States and Europe. Dabur’s overseas revenues now make up over 25% of its total turnover.
Dabur’s FMCG portfolio includes popular brands like Dabur Chyawanprash, Dabur Honitus, Dabur Honey, Dabur Lal Tail and Dabur Pudin Hara in the healthcare segment; Dabur Amla and Dabur Red Paste in the personal care space; and Real in the Food & Beverages category.
The company has a portfolio of 23 brands with sales of more than ₹100 crore. Seventeen of these brands generate sales revenue between ₹100 crore and ₹500 crore.
Dabur India Financial Highlights
- Revenue: Dabur India reported revenue of ₹13,792.34 crore in FY26 vs ₹13,113.19 crore in FY25. It showed an increase of 5.18% on a yearly basis.
- Operating Profit: Dabur India reported an operating profit of ₹2,420.43 crore in FY26 vs ₹2,257.89 crore in FY25. It showed an increase of 7.20% on a year-on-year basis.
- Net Profit: Dabur India reported a net profit of ₹1,868.69 crore in FY26 vs ₹1,740.42 crore in FY25. It showed an increase of 7.37% on a yearly basis.
Dabur India Quarterly Result Highlights
- Dabur India reported revenue of ₹3,213.05 crore in Mar 2026, compared with ₹3,699.29 crore in Dec 2025, representing a decrease of 13.14% on a quarter-on-quarter (QoQ) basis.
- Dabur India reported an operating profit of ₹473.68 crore in Mar 2026, compared with ₹711.11 crore in Dec 2025, representing a decrease of 33.39% on a quarter-on-quarter (QoQ) basis.
- Dabur India reported a profit of ₹362.00 crore in Mar 2026, compared with ₹553.61 crore in Dec 2025, reflecting a decrease of 34.61% on a QoQ basis.
- The earnings per share (EPS) of Dabur India stood at ₹9.97 during Mar 2026.
